tiprankstipranks
Trending News
More News >
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market

Intensity Therapeutics, Inc. (INTS) Financial Statements

Compare
247 Followers

Intensity Therapeutics, Inc. Financial Overview

Intensity Therapeutics, Inc.'s market cap is currently $25.53M. The company's EPS TTM is $-0.06; its P/E ratio is -0.66; Intensity Therapeutics, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -147.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -16.59M$ -8.32M$ -7.55M$ -8.01M$ -6.22M
EBITDA$ -16.27M$ -10.09M$ -7.50M$ -7.88M$ -6.03M
Net Income$ -16.27M$ -10.54M$ -7.58M$ -7.90M$ -5.96M
Balance Sheet
Cash & Short-Term Investments$ 2.59M$ 14.78M$ 1.31M$ 4.54M$ 9.32M
Total Assets$ 4.78M$ 17.30M$ 1.76M$ 5.22M$ 10.15M
Total Debt$ 138.00K$ 158.00K$ 4.49M$ 2.34M$ 497.48K
Net Debt$ -2.45M$ -8.40M$ 3.18M$ -2.20M$ -8.82M
Total Liabilities$ 1.86M$ 4.13M$ 16.86M$ 13.90M$ 11.71M
Stockholders' Equity$ 2.92M$ 13.16M$ -15.10M$ -8.68M$ -1.56M
Cash Flow
Free Cash Flow$ -15.22M$ -7.21M$ -5.48M$ -6.83M$ -5.37M
Operating Cash Flow$ -15.22M$ -7.21M$ -5.48M$ -6.83M$ -5.37M
Investing Cash Flow$ 6.35M$ -6.02M$ 0.00$ 0.00$ 4.56M
Financing Cash Flow$ 2.90M$ 20.47M$ 2.25M$ 2.05M$ 6.29M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

Intensity Therapeutics, Inc. Debt to Assets

Intensity Therapeutics, Inc. Cash Flow

Intensity Therapeutics, Inc. Forecast EPS vs Actual EPS